Free Trial

Longboard Pharmaceuticals (LBPH) News Today

Longboard Pharmaceuticals logo
$59.98 +0.02 (+0.03%)
(As of 11/29/2024 ET)
Longboard Pharmaceuticals, Inc. stock logo
Victory Capital Management Inc. Buys New Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
Victory Capital Management Inc. bought a new stake in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 15,773 shares of the company's stock,
Longboard Pharmaceuticals, Inc. stock logo
Ally Bridge Group NY LLC Acquires 21,911 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
Ally Bridge Group NY LLC lifted its holdings in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 240,892 shar
Longboard Pharmaceuticals, Inc. stock logo
Jennison Associates LLC Sells 34,440 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
Jennison Associates LLC lowered its position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 3.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 917,528 shares of the company's stock after selling 34,44
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Average Recommendation of "Hold" from Brokerages
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have earned a consensus recommendation of "Hold" from the nine research firms that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation and four have given a bu
Longboard Pharmaceuticals, Inc. stock logo
Braun Stacey Associates Inc. Takes Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
Braun Stacey Associates Inc. acquired a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 299,156 shares of the company's stock
Longboard Pharmaceuticals Advances Neurological Treatments
Longboard Pharmaceuticals, Inc. stock logo
Emerald Advisers LLC Grows Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
Emerald Advisers LLC raised its holdings in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 199.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 683,642 shares of the company's stock after acquiring an additional 455,119 sha
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High - Here's What Happened
Longboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Time to Buy?
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have received a consensus rating of "Hold" from the nine ratings firms that are covering the company, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and four have issued a bu
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Sets New 12-Month High - Here's What Happened
Longboard Pharmaceuticals (NASDAQ:LBPH) Sets New 52-Week High - Should You Buy?
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Should You Buy?
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Strong Trading Volume - What's Next?
Longboard Pharmaceuticals, Inc. stock logo
SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
SG Americas Securities LLC bought a new stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 10,514 shares of the company's stock, valued at approximately $350,000. Other l
Longboard Pharmaceuticals, Inc. stock logo
Wedbush Lowers Longboard Pharmaceuticals (NASDAQ:LBPH) to Hold
Wedbush downgraded Longboard Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research report on Monday.
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 5,380,000 shares, a growth of 33.5% from the September 15th total of 4,030,000 shares. Currently, 16.0% of the company's shares are short sold. Based on an average trading volume of 655,600 shares, the days-to-cover ratio is presently 8.2 days.
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Large Volume Increase - Here's Why
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume - Still a Buy?
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Given Neutral Rating at HC Wainwright
HC Wainwright reaffirmed a "neutral" rating and set a $60.00 price target (down previously from $80.00) on shares of Longboard Pharmaceuticals in a research report on Tuesday.
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:LBPH)
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) saw unusually large options trading on Monday. Traders bought 4,265 call options on the company. This represents an increase of 1,960% compared to the average volume of 207 call options.
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Earns Neutral Rating from B. Riley
B. Riley restated a "neutral" rating and set a $60.00 price objective (up from $45.00) on shares of Longboard Pharmaceuticals in a research report on Monday.
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 4.3% - Time to Buy?
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 4.3% - What's Next?
Longboard Pharmaceuticals, Inc. stock logo
The Manufacturers Life Insurance Company Increases Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
The Manufacturers Life Insurance Company increased its position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 40.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,739 shares of the compa
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up - Should You Buy?
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up - Here's Why
Longboard Pharmaceuticals, Inc. stock logo
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Down 6.2% - Here's Why
Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 6.2% - Here's Why
Get Longboard Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter.

Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

LBPH Media Mentions By Week

LBPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LBPH
News Sentiment

0.89

0.87

Average
Medical
News Sentiment

LBPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LBPH Articles
This Week

6

5

LBPH Articles
Average Week

Get Longboard Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LBPH) was last updated on 12/1/2024 by MarketBeat.com Staff
From Our Partners